Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indicationsas graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Paul A. Wagner, PhD$26.9M
Market Cap • 23/04/20242007
(há 17 anos)
2020
(4 years ago)
NASDAQ
Listagem
Dallas
Sede • Texas6
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
FBRXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.